The lack of Gal-1 resulted in remarkable ventricular dilatation, increased dysfunction, and diffuse fibrosis, demonstrating that Gal-1, as a physiological factor, inhibits these adverse features by reducing post-infarction inflammation and driving well-controlled tissue repair [74]. Here, LGALS1 is linked to Vascular dilatation.